Global Cord Blood Corp
OTC:CORBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Global Cord Blood Corp
Note Receivable
Global Cord Blood Corp
Note Receivable Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Global Cord Blood Corp
OTC:CORBF
|
Note Receivable
¥254.8m
|
CAGR 3-Years
34%
|
CAGR 5-Years
14%
|
CAGR 10-Years
0%
|
|
|
B
|
Beijing Health (Holdings) Ltd
HKEX:2389
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Human Health Holdings Ltd
HKEX:1419
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Town Health International Medical Group Ltd
HKEX:3886
|
Note Receivable
HK$15.9m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
China Biotech Services Holdings Ltd
HKEX:8037
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bamboos Health Care Holdings Ltd
HKEX:2293
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Global Cord Blood Corp
Glance View
Global Cord Blood operates as a holding company, which engages in the provision of cord blood banking services. The company employs 1,215 full-time employees The company went IPO on 2009-11-19. The firm and its subsidiaries are principally engaged in the provision of umbilical cord blood storage and ancillary services in the People's Republic of China. The company provides cord blood testing, processing and storage services under the direction of subscribers for a cord blood processing fee and a storage fee. The company also tests, processes and stores donated cord blood, and provides matching services to the public for a fee. The firm provides cord blood processing and storage services for expectant parents interested in capturing the opportunities made available by evolving medical treatments and technologies, such as cord blood transplants. The company also preserves cord blood units donated by the public; provides matching services on such donated units, and delivers matching units to patients in need of transplants.
See Also
What is Global Cord Blood Corp's Note Receivable?
Note Receivable
254.8m
CNY
Based on the financial report for Mar 31, 2022, Global Cord Blood Corp's Note Receivable amounts to 254.8m CNY.
What is Global Cord Blood Corp's Note Receivable growth rate?
Note Receivable CAGR 10Y
0%
Over the last year, the Note Receivable growth was 17%. The average annual Note Receivable growth rates for Global Cord Blood Corp have been 34% over the past three years , 14% over the past five years .
